Table 1.
Variable | nHTX | GEM-nHTX | p |
---|---|---|---|
Albumine (g/l) | 39.1 ± 0.3 | 34.6 ± 0.2 | <0.001 |
Alkaline phosphatase (U/l) | 33.2 ± 2.7 | 41.3 ± 5.6 | 0.221 |
GPT (U/l) | 35.6 ± 1.6 | 34.4 ± 0.6 | 0.482 |
GOT (U/l) | 57.6 ± 2.1 | 55.8 ± 2.1 | 0.544 |
Direct bilirubine (µmol/l) | 0.6 ± 0.1 | 0.4 ± 0.1 | 0.19 |
Total bilirubine (µmol/l) | 1.3 ± 0.2 | 0.7 ± 0.1 | 0.036 |
Total cholesterol (mmol/l) | 2.2 ± 0.1 | 1.7 ± 0.1 | 0.024 |
CK (U/l) | 162.5 ± 8.4 | 163 ± 6.2 | 0.962 |
Creatinine (µmol/l) | 30.1 ± 1.7 | 20.5 ± 1.0 | <0.001 |
HDL cholesterol (mmol/l) | 2.0 ± 0.1 | 1.6 ± 0.1 | 0.004 |
LDL cholesterol (mmol/l) | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.039 |
LDH (U/l) | 137.2 ± 16.7 | 137.5 ± 16.5 | 0.991 |
Triglyceride (mmol/l) | 0.5 ± 0.1 | 1 ± 0.1 | 0.014 |
Carbamide (mmol/l) | 5.4 ± 0.3 | 5.7 ± 0.3 | 0.697 |
The results of biochemical parameters of gemfibrozil- and vehicle-treated non-transplanted groups are shown. The following parameters were studied: albumine, alkaline phophatase, glutamate-pyruvate transaminase (GPT), glutamate oxaloacetate transaminase (GOT), direct and total bilirubine, total cholesterol, creatine kinase (CK), creatinine, high and low-density lipoprotein-cholesterol (HDL, LDL), lactate dehydrogenase (LDH), triglyceride and carbamide. Study groups: gemfibrozil-control group (GEM-nHTX), control-group (nHTX).